Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.

Clicks: 240
ID: 108165
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
souza2020immunerelatedeuropean Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Souza, Ive L;Fernandes, Ítalo;Taranto, Patrícia;Buzaid, Antonio C;Schvartsman, Gustavo;
Journal European journal of cancer (Oxford, England : 1990)
Year 2020
DOI
S0959-8049(20)30336-1
URL
Keywords
immunotherapy pd-1 adverse drug reactions pneumonitis covid-19

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.